Bisphosphonates and oesophageal cancer risk: Where are we now?

被引：3
|
作者：
Rozenberg, Serge [1 ]
Dutton, Susan [2 ]
机构：
[1] Univ Libre Bruxelles, CHU St Pierre, Dept Obstet & Gynaecol, B-1000 Brussels, Belgium
[2] Univ Oxford Wolfson Coll, Ctr Stat Med, Oxford OX2 6UD, England
来源：
MATURITAS | 2011年 / 68卷 / 02期
关键词：
Bisphosphonates; Oesophageal; Cancer; Risk; ORAL BISPHOSPHONATES;
D O I：
10.1016/j.maturitas.2010.10.010
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页码：106 / 108
页数：3
相关论文
共 50 条
  • [1] Oral bisphosphonates a risk factor for oesophageal cancer?
    Reactions Weekly, 2009, 1235 (1) : 2 - 2
  • [2] Oral bisphosphonates not linked to oesophageal cancer risk
    Reactions Weekly, 2010, 1315 (1) : 2 - 2
  • [3] Lead and cancer in humans: Where are we now?
    Steenland, K
    Boffetta, P
    AMERICAN JOURNAL OF INDUSTRIAL MEDICINE, 2000, 38 (03) : 295 - 299
  • [4] Where Are We Now With Bilirubin as a Marker of Vascular Risk?
    Breimer, Lars H.
    ANGIOLOGY, 2014, 65 (03) : 177 - 179
  • [5] Exosomes and solid cancer therapy: where are we now?
    Zemanek, Tomas
    Danisovic, Lubos
    Nicodemou, Andreas
    MEDICAL ONCOLOGY, 2025, 42 (03)
  • [6] Exposure to oral bisphosphonates and risk of cancer
    Cardwell, Chris R.
    Abnet, Christian C.
    Veal, Philip
    Hughes, Carmel M.
    Cantwell, Marie M.
    Murray, Liam J.
    INTERNATIONAL JOURNAL OF CANCER, 2012, 131 (05) : E717 - E725
  • [7] Plant-based vaccines and cancer therapy: Where are we now and where are we going?
    Rahimian, Neda
    Miraei, Hamid Reza
    Amiri, Atefeh
    Ebrahimi, Mohammad Saeid
    Nahand, Javid Sadri
    Tarrahimofrad, Hossein
    Hamblin, Michael R.
    Khan, Haroon
    Mirzaei, Hamed
    PHARMACOLOGICAL RESEARCH, 2021, 169
  • [8] Immunotherapy in Neuroendocrine Neoplasms: Where Are We Now?
    Fazio, Nicola
    Abdel-Rahman, Omar
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2021, 22 (03)
  • [9] Liposomes in Cancer Therapy: How Did We Start and Where Are We Now
    Fulton, Melody D. D.
    Najahi-Missaoui, Wided
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (07)
  • [10] Ergothioneine, where are we now?
    Halliwell, Barry
    Cheah, Irwin
    FEBS LETTERS, 2022, 596 (10) : 1227 - 1230
12345